Secretive 'rebate trap' keeps generic drugs for diabetes and other ills out of reach

This is a Kaiser Health News story. Lisa Crook was lucky. She saved $ 800 last year after her insurance company started covering a new, less expensive insulin called Basaglar that was virtually identical to the brand she had used for years. The list price for Lantus, a long-acting insulin made by Sanofi that she… Read More »